Travis Alvin Thompson - 11 Nov 2024 Form 4 Insider Report for BICYCLE THERAPEUTICS PLC (BCYC)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
BCYC
Transactions as of
11 Nov 2024
Net transactions value
-$142,505
Form type
4
Filing time
13 Nov 2024, 19:43:02 UTC
Previous filing
04 Oct 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $2,453 +1,312 +5.7% $1.87 24,234 11 Nov 2024 Direct F1, F2
transaction BCYC Ordinary Shares Sale $32,866 -1,312 -5.4% $25.05 22,922 11 Nov 2024 Direct F1, F3
transaction BCYC Ordinary Shares Options Exercise $1,264 +154 +0.67% $8.21 23,076 11 Nov 2024 Direct F1, F2
transaction BCYC Ordinary Shares Sale $3,852 -154 -0.67% $25.01 22,922 11 Nov 2024 Direct F1, F4
transaction BCYC Ordinary Shares Options Exercise $10,890 +1,109 +4.8% $9.82 24,031 11 Nov 2024 Direct F1
transaction BCYC Ordinary Shares Sale $27,780 -1,109 -4.6% $25.05 22,922 11 Nov 2024 Direct F1, F3
transaction BCYC Ordinary Shares Sale $81,706 -3,241 -14% $25.21 19,681 11 Nov 2024 Direct F1
transaction BCYC Ordinary Shares Sale $5,177 -209 -1.1% $24.77 19,472 11 Nov 2024 Direct F1, F5
transaction BCYC Ordinary Shares Sale $5,733 -231 -1.2% $24.82 19,241 11 Nov 2024 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Employee Stock Option (right to buy) Options Exercise $0 -1,312 -33% $0.000000 2,617 11 Nov 2024 Ordinary Shares 1,312 $1.87 Direct F1, F2, F7
transaction BCYC Employee Stock Option (right to buy) Options Exercise $0 -154 -34% $0.000000 302 11 Nov 2024 Ordinary Shares 154 $8.21 Direct F1, F2, F7
transaction BCYC Employee Stock Option (right to buy) Options Exercise $0 -1,109 -7.9% $0.000000 12,954 11 Nov 2024 Ordinary Shares 1,109 $9.82 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024.
F2 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.08 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.81 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $24.825 inclusive.
F7 This option is fully vested and exercisable.